graduated from Shandong Medical College in China and then obtained his Ph.D from University of Illinois at Chicago. Following the postdoctoral training in NCI of NIH in Bethesda, MD, he moved to Columbia University Medical Center, working in Dr. Alan Tall’s lab in Department of Medicine. He is currently Associate Professor of Medical Sciences at CUMC. His main research interest is atherosclerotic cardiovascular disease. His earlier work was to evaluate the role of HDL metabolism and mechanisms responsible for regulation of cellular cholesterol efflux in atherogenesis. Currently, his research is focused on assessing genetic polymorphisms or mutations that affect atherogenesis by modulating hematopoiesis and inflammatory responses.
earned her BS and MD degrees from Tianjin Medical University in 2013 and 2018, respectively. She now works as a postdoctoral research scientist studying the molecular mechanisms of clonal hematopoiesis (CH) and CH-associated cardiovascular diseases in the laboratory of Dr. Alan Tall at Columbia University. Her current focus is modeling the effect of Jak2VF on erythropoiesis and atherosclerosis. Her hope is that her research will continue to contribute to the groundwork for developing cardiac therapies that will benefit the tens of millions of patients who suffer from cardiovascular disease. When not at the bench, Dr. Liu enjoys cooking spicy foods.
obtained her HBSc at the Department of Immunology, University of Toronto and her MD/PhD studies under the supervision of Prof. Tak Mak at the University of Toronto. Upon completion of Internal Medicine Residency training at the University of Toronto, she moved to Boston for Cardiology Fellowship training at Brigham and Women’s Hospital, Harvard Medical School. She is now a postdoctoral research fellow in Cardiovascular Medicine and Hematology with Prof. Benjamin Ebert, at Brigham and Women’s Hospital and Dana Farber Cancer Institute.
is a hematologist and postdoctoral fellow in the Hidalgo laboratory at CNIC. She has studied hematopoietic niche in bone marrow and myelofibrosis/osteosclerosis complicated with myeloproliferative neoplasm. She would like to reveal how innate immune cells communicate with the hematopoietic niche in bone marrow, and whether this process is altered during Clonal Hematopoiesis.
is at Stanford University with Dr. Siddhartha Jaiswal’s lab, where he is interested in exploring how loss of function of epigenetic modifiers with opposing functions, namely Tet2 and DNMT3a, converge in a subset of hematopoietic stem cells on a similar atherogenic phenotype
did his graduate studies on Biology and Master studies at Universidad Complutense de Madrid, working on the role of innate immunity in stroke under the supervision of Dr. María Angeles Moro. After a postdoctoral position at the Kings College London and at the Memorial Sloan Kettering Cancer Center he joined the laboratory of Dr. Andrés Hidalgo to explore the heterogeneity of neutrophils under homeostasis.